Evidence map›Paper›PMID 41828669›Full record

ArticleInternational journal of molecular sciences2026

Pathogenicity Prediction of Missense Variations in Hereditary Cancer Genes.

Cemaliye B Akyerli, Gizel Gerdan, Alper Bülbül, Hilal Keskin-Karakoyun, Şirin K Yüksel, Emel Timucin

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Cemaliye B AkyerliDepartment of Medical Biology, School of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul 34638, Türkiye.ORCID 0000-0002-7263-2969
Gizel GerdanDepartment of Genome Studies, Graduate School of Health Sciences, Acibadem Mehmet Ali Aydinlar University, Istanbul 34638, Türkiye.ORCID 0009-0001-5886-3269
Alper BülbülDepartment of Biostatistics and Bioinformatics, Graduate School of Health Sciences, Acibadem Mehmet Ali Aydinlar University, Istanbul 34638, Türkiye.ORCID 0000-0001-5359-4357
Hilal Keskin-KarakoyunDepartment of Biochemistry and Molecular Biology, Graduate School of Health Sciences, Acibadem Mehmet Ali Aydinlar University, Istanbul 34638, Türkiye.ORCID 0000-0001-6886-3986
Şirin K YükselDepartment of Biochemistry and Molecular Biology, Graduate School of Health Sciences, Acibadem Mehmet Ali Aydinlar University, Istanbul 34638, Türkiye.ORCID 0000-0002-7130-2933
Emel TimucinDepartment of Molecular Biology and Genetics, Gebze Technical University, Kocaeli 41400, Türkiye.ORCID 0000-0003-0048-0668

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HerCanPred, a machine-learning-based pathogenicity classifier specifically optimized for 63 cancer-predisposition genes, was developed to improve the interpretation of missense variants in hereditary cancer syndromes. This model integrates sequence conservation with structural features derived from AlphaFold2 (AF2) structures. HerCanPred achieved a strong performance, outperforming 23 established predictors. SHAP analysis identified AF2-derived structural features, specifically local pLDDT confidence scores and relative solvent accessible area, as the strongest predictors of variant impact. Benchmarking the strengths and limitations of HerCanPred against existing methods showed that misclassification of pathogenic variants was concentrated in disordered and surface-exposed regions, whereas benign failures were more broadly distributed. HerCanPred and three established predictors were also applied to over 57,000 variants of uncertain significance (VUS) from the same gene set. Notably, 166 VUS were reassigned as pathogenic and 75 as benign, with an enrichment of the

Indexed as

Genes, NeoplasmGenetic Predisposition to DiseaseMachine LearningMutation, MissenseNeoplasmsConserved SequenceHumansProtein FoldingProtein Interaction MapsUncertaintyAlphaFold2hereditary cancerpathogenicity classificationVUS

Identifiers

PMID41828669
PMCPMC12985416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.